Clinical Trial Update: A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating subcutaneous Mircera for chronic renal anemia in dialysis patients has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 2 | Status: COMPLETED | Results posted: 2016-12-20